These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14016115)

  • 41. Electrocardiographic effects of antimony dimercapto-succinate ('astiban').
    SOMERS K; ROSANELLI JD
    Br Heart J; 1962 Mar; 24(2):187-91. PubMed ID: 13915096
    [No Abstract]   [Full Text] [Related]  

  • 42. The "lung shift" of Schistosoma mansoni in mice following therapy with tartar emetic or miracil D.
    HEWITT R; GILL E
    Am J Trop Med Hyg; 1960 Jul; 9():402-9. PubMed ID: 14401609
    [No Abstract]   [Full Text] [Related]  

  • 43. Antimony dimercaptosuccinate (TWSb) in the treatment of urinary bilharziasis in Somalia.
    BARUFFA G; FRIEDHEIM EA
    Cent Afr J Med; 1960 Nov; 6():485-7. PubMed ID: 13687532
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of schistosomiasis mansoni with antimony-omega, omega-dimercapto-potassium succinate (TWSb).
    FRIEDHEIM EA; DA SILVA JR; MARTINS AV
    Am J Trop Med Hyg; 1954 Jul; 3(4):714-27. PubMed ID: 13180832
    [No Abstract]   [Full Text] [Related]  

  • 45. "Lung shift" in mice infected with Schistosoma mansoni following chemotherapy.
    GEAKE CR
    Am J Trop Med Hyg; 1962 Jul; 11():477-80. PubMed ID: 13897408
    [No Abstract]   [Full Text] [Related]  

  • 46. "ASTIBAN" THERAPY IN BILHARZIASIS; ITS URINARY EXCRETION ESTIMATED BY A NEW POLAROGRAPHIC TECHNIQUE.
    RIFAAT MA; KHALIL HM; WOODRUFF AW
    J Trop Med Hyg; 1964 May; 67():121-2. PubMed ID: 14144766
    [No Abstract]   [Full Text] [Related]  

  • 47. [Therapeutic evaluation of antimony and sodium dimercaptosuccinate in the treatment of schistosomiasis mansoni].
    Siqueira MW; Huggins D
    Rev Bras Med; 1967 Feb; 24(2):97-9. PubMed ID: 5604907
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of schistosomiasis mansoni with antimony lithium thiomalate (Anthiomaline); final report.
    RODRIGUEZ-MOLINA R; ACEVEDO CE; TORRES JM; LOPEZ-SANABRIA U; RAMIREZ-RODRIGUEZ E
    Am J Trop Med Hyg; 1950 Nov; 30(6):881-6. PubMed ID: 14790178
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapeutic use of antimony and sodium dimercaptosuccinate in the treatment of schistosomiasis mansoni].
    Teixeira D; de Gouveia OF; Miyahira AR; Galper E; da Cunha MA
    Hospital (Rio J); 1965 Dec; 68(6):1361-75. PubMed ID: 5296034
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of a subcurative dose of TWSb on the levels of phosphate esters in Schistosoma mansoni.
    Fisher J; Bruce JI; Bourgeois JG; Bueding E; Sadun EH
    Am J Trop Med Hyg; 1966 Jul; 15(4):507-9. PubMed ID: 4223154
    [No Abstract]   [Full Text] [Related]  

  • 51. REPEATED INFECTION AND TREATMENT OF MICE WITH SCHISTOSOMA MANSONI: FUNCTIONAL, ANATOMIC AND IMMUNOLOGIC OBSERVATIONS.
    CHEEVER AW; DEWITT WB; WARREN KS
    Am J Trop Med Hyg; 1965 Mar; 14():239-53. PubMed ID: 14270449
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of the substituent radicals in antimonyl naphthalein derivatives on the potentialities of anti-schistosomal activity in mice.
    Ghaleb HA; Shoeb HA; el-Gawhary N; el-Borolossy AW; el-Halawany SA; MADKOUR MK
    J Egypt Med Assoc; 1979; 62(1-2):31-43. PubMed ID: 262474
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of urinary bilharziasis with antimony dimercaptosuccinate (TWSb).
    ALVES W
    Cent Afr J Med; 1958 Jan; 4(1):15. PubMed ID: 13511426
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of schistosomiasis mansoni with antimony lithium thiomalate (anthiomaline).
    HERNANDEZ MORALES F; SUAREZ RM
    PR J Public Health Trop Med; 1946 Jun; 21():336-43, Spanish transl 344-9. PubMed ID: 20996524
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of schistosomiasis, past & present. II. Clinical investigations on the treatment of urinary and intestinal bilharziasis with TWSb (antimonv dimercaptosuccinate) with a critical study of its toxic side effects.
    NAGATY HF; RIFAAT MA
    J Egypt Med Assoc; 1960; 43():678-95. PubMed ID: 13727430
    [No Abstract]   [Full Text] [Related]  

  • 56. Screening of three synthetic organic trivalent antimonials for potential antischistosomal activity in mice.
    Ghaleb HA; Shoeb H; el-Kawhary N; el-Borolossy AW; el-Halawany SA; Madkour MK
    J Egypt Med Assoc; 1979; 62(1-2):1-29. PubMed ID: 262466
    [No Abstract]   [Full Text] [Related]  

  • 57. [Schistosomiasis clinically active for 25 years].
    Salmon F; Sidi Y; Pinkhas J
    Harefuah; 1980 Jan; 98(1):22-3. PubMed ID: 6248410
    [No Abstract]   [Full Text] [Related]  

  • 58. HUMAN DISPOSITION OF ANTIMONY ADMINISTERED AS ANTIMONY SODIUM DIMERCAPTO-SUCCINATE. WITH AN ANALYSIS OF ANTIMONY CONCENTRATION IN EXCRETED SCHISTOSOMA HAEMATOBIUM OVA.
    SCHULERT AR; BROWNE HG; SALEM HH
    Trans R Soc Trop Med Hyg; 1964 Jan; 58():48-52. PubMed ID: 14117554
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic trials with TWSb (dimercaptosuccinate of antimony) in vesical bilharziasis. I. Results obtained in a school infirmary (Hospital do Ultramar) in Lisbon. II. Results obtained in the Hospital de S. Paulo de Luanda. III. Results obtained in Guinea in the infirmary of the Endemia Mission].
    OLIVEIRA CF; ROCHA RM; LEITAO MS; SA AP; BARBOSA F; ATAIDE P; CRUZ FS; da CUNHA C; GARCIA LN
    An Inst Med Trop (Lisb); 1960 Sep; 17():669-96. PubMed ID: 14481781
    [No Abstract]   [Full Text] [Related]  

  • 60. Suppressive therapy with MsbE and Astiban in hamsters infected with Schistosoma mansoni.
    Baldewsing R
    Trop Geogr Med; 1973 Jun; 25(2):174-8. PubMed ID: 4736841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.